Literature DB >> 20660167

The hidden life of NAD+-consuming ectoenzymes in the endocrine system.

Fabio Malavasi1, Silvia Deaglio, Gianluca Zaccarello, Alberto L Horenstein, Antonella Chillemi, Valentina Audrito, Sara Serra, Marina Gandione, Andrea Zitella, Alessandro Tizzani.   

Abstract

Ectoenzymes are a family of cell surface molecules whose catalytic domain lies in the extracellular region. A subset of this family, nucleotide-metabolizing ectoenzymes, are key components in the regulation of the extracellular balance between nucleotides (e.g. NAD(+) or ATP) and nucleosides (e.g. adenosine). Their substrates and products are signalling molecules that act by binding to specific receptors, triggering signals that regulate a variety of functions, ranging from the migration of immune cells, to synaptic transmission in the brain, to hormone/receptor interactions in the glands. Almost two decades of accumulated data indicate that these regulatory processes significantly affect the endocrine system, a tightly controlled information signal complex with clear evidence of fine regulation. Functional models discussed in this review include insulin secretion, bone modelling and the association between hormones and behaviour. The emerging pattern is one of a system operating as a scale-free network that hinges around hubs of key molecules, such as NAD(+) or ATP. The underlying natural link between nucleotides, ectoenzymes and the endocrine system is far from being clearly demonstrated. However, the body of evidence supporting the existence of such connection is growing exponentially. This review will try to read the available evidence in a hypothesis-oriented perspective, starting from the description of NAD(+) and of ecto- and endoenzymes involved in its metabolism.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20660167     DOI: 10.1677/JME-10-0082

Source DB:  PubMed          Journal:  J Mol Endocrinol        ISSN: 0952-5041            Impact factor:   5.098


  12 in total

1.  Targeting of NAD metabolism in pancreatic cancer cells: potential novel therapy for pancreatic tumors.

Authors:  Claudia C S Chini; Anatilde M Gonzalez Guerrico; Veronica Nin; Juliana Camacho-Pereira; Carlos Escande; Maria Thereza Barbosa; Eduardo N Chini
Journal:  Clin Cancer Res       Date:  2013-09-11       Impact factor: 12.531

Review 2.  CD38 and chronic lymphocytic leukemia: a decade later.

Authors:  Fabio Malavasi; Silvia Deaglio; Rajendra Damle; Giovanna Cutrona; Manlio Ferrarini; Nicholas Chiorazzi
Journal:  Blood       Date:  2011-07-15       Impact factor: 22.113

3.  Oct-4+/Tenascin C+ neuroblastoma cells serve as progenitors of tumor-derived endothelial cells.

Authors:  Annalisa Pezzolo; Federica Parodi; Danilo Marimpietri; Lizzia Raffaghello; Claudia Cocco; Angela Pistorio; Manuela Mosconi; Claudio Gambini; Michele Cilli; Silvia Deaglio; Fabio Malavasi; Vito Pistoia
Journal:  Cell Res       Date:  2011-03-15       Impact factor: 25.617

4.  Cellular Compartmentation and the Redox/Nonredox Functions of NAD.

Authors:  Chaitanya A Kulkarni; Paul S Brookes
Journal:  Antioxid Redox Signal       Date:  2019-03-26       Impact factor: 8.401

5.  All-trans retinoic acid upregulates reduced CD38 transcription in lymphoblastoid cell lines from Autism spectrum disorder.

Authors:  Mathias Riebold; David Mankuta; Elad Lerer; Salomon Israel; Songfa Zhong; Luba Nemanov; Mikhail V Monakhov; Shlomit Levi; Nurit Yirmiya; Maya Yaari; Fabio Malavasi; Richard P Ebstein
Journal:  Mol Med       Date:  2011-04-25       Impact factor: 6.354

Review 6.  Anti-CD38 antibody therapy: windows of opportunity yielded by the functional characteristics of the target molecule.

Authors:  Antonella Chillemi; Gianluca Zaccarello; Valeria Quarona; Manuela Ferracin; Chiara Ghimenti; Massimo Massaia; Alberto L Horenstein; Fabio Malavasi
Journal:  Mol Med       Date:  2013-05-20       Impact factor: 6.354

Review 7.  Electroosmotic perfusion of tissue: sampling the extracellular space and quantitative assessment of membrane-bound enzyme activity in organotypic hippocampal slice cultures.

Authors:  Yangguang Ou; Juanfang Wu; Mats Sandberg; Stephen G Weber
Journal:  Anal Bioanal Chem       Date:  2014-08-29       Impact factor: 4.142

8.  Targeting CD38 with daratumumab is lethal to Waldenström macroglobulinaemia cells.

Authors:  Aneel Paulus; Alak Manna; Sharoon Akhtar; Shumail M Paulus; Mayank Sharma; Marie V Coignet; Liuyan Jiang; Vivek Roy; Thomas E Witzig; Stephen M Ansell; John Allan; Richard Furman; Sonikpreet Aulakh; Rami Manochakian; Sikander Ailawadhi; Asher A Chanan-Khan; Taimur Sher
Journal:  Br J Haematol       Date:  2018-08-06       Impact factor: 6.998

Review 9.  Purinergic signalling in endocrine organs.

Authors:  Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2013-11-22       Impact factor: 3.765

10.  Nicotinamide, NAD(P)(H), and Methyl-Group Homeostasis Evolved and Became a Determinant of Ageing Diseases: Hypotheses and Lessons from Pellagra.

Authors:  Adrian C Williams; Lisa J Hill; David B Ramsden
Journal:  Curr Gerontol Geriatr Res       Date:  2012-03-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.